Comparison of ELISA and Pharmacia UNICAP detection reagent for House dust mite specific IgG4
-
摘要: 目的:对屋尘螨特异性IgG4 ELISA检测试剂与法玛西亚UNICAP IgG4检测试剂进行对比研究。方法:首先对屋尘螨特异性IgG4 ELISA检测试剂相关性能指标进行研究。对比ELISA试剂与法玛西亚UNICAP检测试剂的浓度校准曲线。同时采用以上2种检测试剂和方法,对临床上65份行屋尘螨特异性免疫治疗患者的血清标本进行检测,并对检测结果进行相关分析。结果:屋尘螨特异性IgG4 ELISA检测试剂具有良好的性能指标(批内差CV=3.48%,批间差CV=5.78%)。ELISA试剂与法玛西亚UNICAP检测试剂的校准曲线非常相似,在0.003~0.150 μg/ml检测范围内呈现良好的线性关系。对临床上特异性免疫治疗前后65份血清进行检测,ELISA与法玛西亚UNICAP检测结果相关系数为0.93。结论:屋尘螨特异性IgG4 ELISA检测试剂与法玛西亚UNICAP检测试剂具有良好的一致性,可望在临床上广泛开展应用。Abstract: Objective: To compare the ELISA and Pharmica unicap reagents of Dermatophagoides pteronyssinus specific IgG4 in clinic.Method: The stability of ELISA reagent was studied first with parameters of intra and inter assay variations (%CV). Calibration curve of the two reagents was compared. Sixty-five serum samples before or after standardized specific immunotherapy were examined with the two methods, correlation coefficient was calculated.Result: The stability of ELISA reagent was good with low intra and inter assay variations(3.48% and 5.78%). Calibration curve of the two reagents was similar. The correlation coefficient was 0.93 between the two test methods.Conclusion: The results of ELISA and Pharmica unicap reagents of Dermatophagoides pteronyssinus specific IgG4 were highly consistent. The ELISA reagents could be applied in clinic.
-
Key words:
- house dust mite /
- allergic rhinitis /
- specific IgG4 /
- ELISA /
- UNICAP
-
-
[1] MATSUI E C, DIETTE G B, KROP E J,et al.Mouse allergen-specific immunoglobulin G and immunoglobulin G4 and allergic symptoms in immunoglobulin E-sensitized laboratory animal workers[J]. Clin Exp Allergy,2005,35:1347-1353.
[2] NOURI-ARIA K T, WACHHOLZ P A, FRANCIS J N,et al. Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity[J]. J Immunol,2004, 172:3252-3259.
[3] LI J, SUN B, HUANG Y,et al. A multicentre study assessing the prevalence of sensitizations in patients with asthma and/or rhinitis in China[J]. Allergy 2009, 64:1083-1092.
[4] WANG H. A double-blind, placebo-controlled study of house dust mite immunotherapy in Chinese asthmatic patients[J].Allergy, 2006,61:191-197.
[5] 张新梅,贺学英,朱望,等.YY/T 1183-2010,中华人民共和国医药行业标准,酶联免疫吸附法检测试剂(盒)[S].国家药品食品监督管理局,2010:3-6.
[6] AKDIS M, CEZMI A, AKDIS C A. Mechanisms of allergen-specific immunotherapy[J]. J Allergy Clin Immunol,2007,119:780-789.
[7] AALBERSE R C, DIEGES P H, KNUL-BRETLOVA V, et al. IgG4 as a blocking antibody[M]. In:Halpern GM, ed. Clinical reviews in allergy, Vol. 1. New York:Elsevier Biomedical.1983:289-302.
[8] POWELL R J. Effect of grass pollen immunotherapy with Alutard SQ on quality of life in seasonal allergic rhinoconjunctivitis[J].Allergy,2007,62:1335-1338.
[9] BLUMBERG A. Steroid-sparing effect of subcutaneous SQ-standardised specific immunotherapy in moderate and severe HDM allergic asthmatic[J].Allergy,2006,61:843-848.
[10] DURHAM S R. Long-term clinical efficacy of grass-pollen immunotherapy[J].New England J Medicine,1999,341:468-475.
[11] JACOBSEN L. Specific Immunotherapy has long-term preventive effect of seasonal and perennial asthma:10 years follow-up on the PAT study[J].Allergy,2007,62:943-948.
[12] PAJNO G B. Prevention of new sensitizations in asthmatic children monosensitized to House Dust Mite by Specific Immunotherapy. A 6-year follow-up study[J].Clin Exp Allergy,2001,31:1392-1397.
-
计量
- 文章访问数: 139
- PDF下载数: 101